Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesInnovotech Inc

Innovotech Inc

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.065 CAD -0.01 ( 7.14%)
Last update at 2026-11-04T20:05:00Z
VOLUME
97114
Market Cap
10.34M

Momentum Score

…

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.07
Low
0.07
High
52 Week Price Range
0.13
Low
0.34
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Innovotech Inc (IOT.V) is limited; the company is listed on the TSX Venture Exchange and detailed operating descriptions and filings are not readily available in broad public sources. Because available information is sparse, major long-term growth drivers are unclear and investors should monitor company filings and operational updates to assess prospects.

Key investment risks include lack of transparent disclosures, low trading liquidity, execution and financing risk typical of small-cap TSXV issuers and potential regulatory or operational uncertainties.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.07
Dividend Yield
-
Revenue TTM
4.53M
Revenue Per Share
0.09
Gross Profit TTM
2.40M
Debt / Equity
-
ROE
2.79%
Net Debt
-
ROCE
0.61%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 0.09M 0.21M -0.16M -0.14M 0.37M
Minority interest 0.01M 0.01M 0.00M - -
Net income 0.09M 0.22M -0.16M -0.14M 0.37M
Selling general administrative 2.27M 1.01M 0.69M 0.83M 0.82M
Gross profit 2.40M 1.11M 0.48M 0.78M 1.12M
Reconciled depreciation 0.14M 0.06M 0.08M 0.11M 0.07M
Ebit - - - - 0.27M
Ebitda - - - -0.02M 0.44M
Operating income 0.02M 0.05M -0.38M -0.14M 0.27M
Interest expense 0.03M 0.01M 0.00M 0.01M 0.00M
Tax provision 0.00M - - - -
Interest income 0.01M 0.00M 0.01M 0.01M 0.02M
Net interest income -0.02M -0.01M 0.01M 0.00M 0.01M
Total revenue 4.53M 2.19M 1.18M 1.13M 1.48M
Total operating expenses 4.51M 2.15M 1.56M 1.27M 1.21M
Cost of revenue 2.14M 1.08M 0.70M 0.35M 0.36M
Total other income expense net 0.09M 0.17M 0.21M - 0.09M
Net income from continuing ops 0.09M 0.21M -0.16M -0.14M 0.37M
Net income applicable to common shares - - - - 0.37M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 4.43M 3.22M 1.22M 1.22M 1.43M
Intangible assets 0.47M 0.54M 0.16M - -
Total liab 0.78M 0.60M 0.22M 0.17M 0.26M
Total stockholder equity 3.60M 2.57M 0.93M 1.06M 1.18M
Other current liab 0.07M 0.07M - - 0.03M
Common stock - - - - 7.70M
Capital stock 9.93M 8.84M 7.70M 7.70M 7.70M
Retained earnings -8.23M -8.32M -8.55M -8.39M -8.26M
Cash 1.62M 0.73M 0.16M 0.47M 0.42M
Total current liabilities 0.52M 0.42M 0.18M 0.17M 0.22M
Other stockholder equity - - - - 0.16M
Property plant equipment - - - - 0.23M
Total current assets 3.02M 1.68M 0.57M 0.83M 0.99M
Long term investments - 0.50M 0.33M 0.21M -
Net tangible assets - - - - 1.18M
Short term investments - 0.00M 0.07M 0.08M 0.07M
Net receivables 0.51M 0.54M 0.20M 0.18M 0.38M
Long term debt 0.16M - - - -
Inventory 0.19M 0.13M 0.07M 0.04M 0.06M
Accounts payable 0.38M - - - 0.10M
Non current assets total 1.41M 1.54M 0.65M 0.40M 0.44M
Capital lease obligations - - 0.00M 0.04M 0.12M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.55M -0.49M -0.04M -0.07M -0.06M
Change to liabilities - - - - -0.02M
Total cashflows from investing activities - - - - -0.06M
Net borrowings 0.20M 0.00M -0.04M - -0.07M
Total cash from financing activities 0.88M 1.14M -0.04M -0.09M -0.07M
Change to operating activities - - - - -0.09M
Net income 0.09M 0.22M -0.16M -0.14M 0.37M
Change in cash 0.89M 0.56M -0.31M 0.05M -0.11M
Begin period cash flow 0.73M 0.16M 0.47M 0.42M 0.53M
End period cash flow 1.62M 0.73M 0.16M 0.47M 0.42M
Total cash from operating activities -0.06M -0.08M -0.23M 0.21M 0.03M
Issuance of capital stock 0.00M 1.13M 0.00M - 0.00M
Depreciation 0.14M 0.06M 0.08M 0.11M 0.07M
Dividends paid 0.00M 0.00M 0.00M - 0.00M
Change to inventory -0.06M -0.06M -0.03M 0.02M -0.02M
Change to account receivables 0.04M -0.43M -0.02M 0.17M -0.24M
Change to netincome - - - - -0.04M
Capital expenditures 0.47M 0.20M 0.04M 0.07M 0.06M
Change in working capital -0.23M -0.21M -0.05M 0.21M -0.37M
Stock based compensation 0.12M 0.05M 0.03M 0.02M 0.05M
Other non cash items -0.10M -0.03M 0.08M 0.01M -0.09M
Free cash flow -0.53M -0.28M -0.27M 0.14M -0.04M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
IOT
Innovotech Inc		 -0.01
7.14%		 0.07 - - 2.28 2.88 1.96 33.59
SHRX
Sharp Therapeutics Corp.		 -
-%		 1.37 - - - 32.37 - -
NRX
NurExone Biologic Inc.		 -0.01
2.00%		 0.49 - 6.90 - 15.26 - -7.24
MIR
MedMira Inc		 -
-%		 0.06 - - 223.37 - 293.42 -80.03
TTI
Thiogenesis Therapeutics Corp.		 -
-%		 0.63 - - - 15.17 - -58.16

Profile*

Innovotech Inc

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.

2011-94 Street, Edmonton, AB, Canada, T6N 1H1

780-448-0585

https://innovotech.ca

Name Title Year Born
Dr. James Timourian Ph.D. Chairman, CEO, Pres & Sec. NA
Mr. Alan C. Savage CFO & Director 1943
Dr. Tyler Boone Chief Operating Officer NA
Dr. Patricia Nadworny Chief Scientific Officer and Quality & Safety Director NA
Dr. Merle Olson Scientific Consultant NA
Dr. James Timourian Ph.D. Chairman & Secretary NA
Dr. Craig Milne B.Sc., M.B.A., Ph.D. President, CEO & Director NA
Mr. Bernard Grobbelaar C.A., CPA, CA, CPA Chief Financial Officer NA
Dr. Tyler Boone Ph.D. Chief Operating Officer NA
Dr. Patricia Nadworny P.Eng., Ph.D. Chief Scientific Officer and Quality & Safety Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…